Autopsy report · NCT00539500

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow Accrual.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 4 years 11 months before it stopped.
3 participants enrolled.
Results were posted on the registry 6 years 8 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2, Phase 3
Sponsor: M.D. Anderson Cancer Center
Sponsor type: University, hospital or other
Conditions: Neuroblastoma
Interventions: Carboplatin; Etoposide; Melphalan; Stem Cell Infusion; ClinicMACS
Participants: 3
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.